Stock Exchange & Press Releases 2017

Print Print this release
May 04, 2017

Bittium Faros™ ECG-measuring devices’ arrhythmia detection algorithms received medical device approval in Europe

Press release

Free for publication on May 4, 2017 at 10am (CEST +1)

Bittium Faros™ ECG-measuring devices’ arrhythmia detection algorithms received medical device approval in Europe

Oulu, Finland, May 4, 2017 - Bittium Faros ECG-measuring devices’ built-in algorithms for detection of arrhythmias have received medical device approval in Europe. The algorithms can be used to automatically identify sequences from the heart measurement data that include atrial fibrillation, tachycardia, bradycardia, and pauses in the operation of the heart. Early detection of atrial fibrillation can be used to predict the risk of stroke and to prevent its emergence with timely treatment initiation. These new medical device approved algorithms for detection of arrhythmias are available now with Faros ECG-measuring devices.

The new functions allow focusing only on the interesting events even in measurements that last for several days or weeks. In remote monitoring applications Faros devices’ arrhythmia detection algorithms help health care providers to react faster to changes in patients’ state of health. Faros technology is also used in Holtering as well as in group monitoring in cardiac rehabilitation.

Faros product family

Faros is a versatile ECG device that is used for early detection of cardiac abnormalities in everyday life. Faros is ultra-small and lightweight, which enables precise long-term full disclosure ECG measurements for long-term Holtering, cardiac event monitoring, mobile cardiac telemetry and assessing autonomic nervous system functioning.

The Faros outpatient monitoring solutions include several software options for cardiac monitoring. The built-in arrhythmia detection algorithms of the Faros device are used for event recording and mobile event monitoring that enable earlier repatriation of patients and even better ability to react to potentially emerging arrhythmias faster. The new, innovative and sophisticated Holter analysis software increases the accuracy and speeds up the analyzing work significantly.

Faros Cardiac Rehab is a solution for cardiac rehabilitation real-time monitoring for up to 16 patients simultaneously. The system offers safety and efficiency for cardiac rehabilitation by showing each patient’s heart rate, ECG and changes in ST-segment. Utilization of the latest wireless technology allows complete freedom to choose different exercises in various training environments.

More information on the offering:

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507

Main media


Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. From November 2016 onwards, Bittium offers its customers also healthcare technology products and services in biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2016 was EUR 64.2 million and operating profit was EUR 2.5 million. Bittium is listed on Nasdaq Helsinki. .